A Phase 2 Open-Label Randomized Study of V940 in Combination with BCG Versus BCG Monotherapy in Participants with High-Risk Non-Muscle Invasive Bladder Cancer (INTerpath-011)

Phase

Phase I/II Clinical Trial

Trial Number

06833073

Trial Status

OPEN